SCHEMBL6216799

SCHEMBL6216799

Cc1nc(Oc2ccccc2)c([N+](=O)[O-])c(NCC(C)(C)O)c1C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 5/20 0.36
TP53 P04637 1/20 0.36
PDCD1 Q15116 1/20 0.36
CD274 Q9NZQ7 1/20 0.36
EGFR P00533 1/20 0.36
PIN1 Q13526 1/20 0.36
HTT P42858 2/20 0.35
GAA P10253 1/20 0.35
MEN1 O00255 3/20 0.35
KMT2A Q03164 3/20 0.35
RXFP1 Q9HBX9 1/20 0.35
MAPT P10636 6/20 0.34
ALDH1A1 P00352 5/20 0.34
SMN1; SMN2 Q16637 1/20 0.33
NPSR1 Q6W5P4 2/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
XDH P47989 1/20 0.33
GRIN1 Q05586 1/20 0.32
GRIN2B Q13224 1/20 0.32
MITF O75030 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6092975 0.88 LMNA (0.36) LMNATP53PIN1HTTGAA
SCHEMBL5333576 0.84 MAPT (0.42) LMNATP53EGFRPIN1HTT
SCHEMBL4769141 0.83 POLB (0.40) LMNATP53PIN1HTTMEN1
SCHEMBL842636 0.82 PIN1 (0.39) LMNATP53EGFRPIN1HTT
SCHEMBL4837631 0.82 LMNA (0.38) LMNATP53PIN1HTTMEN1
SCHEMBL4829956 0.81 MAPT (0.41) LMNATP53EGFRPIN1HTT
SCHEMBL4773614 0.81 MAPT (0.47) LMNATP53PIN1HTTGAA
SCHEMBL6096324 0.81 BCHE (0.42) LMNATP53
SCHEMBL4771390 0.81 LMNA (0.37) LMNATP53PIN1HTTMEN1
SCHEMBL4769051 0.81 LMNA (0.37) LMNATP53PIN1HTTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1511746-A2 PROCESS FOR IMIDAZO[4,5-C]PYRIDIN-4-AMINES 3M Innovative Properties Company (US) 2005-03-09 EP disclosed
US-6743920-B2 CHORINATION REPLACING HYDROXYL GROUPS OF 2,4-DIHYROXY-3-NITROPYRIDINE DERIVATIVE; AMINATION, HYDROXYARYLATION, REDUCTION AND CYCLIZATION; AMINE REPLACEMENT OF PHENOXY FUNCTIONALITY 3M INNOVATIVE PROPERTIES COMPANY 2004-06-01 US disclosed
US-20030232852-A1 Process for imidazo[4,5-c]pyridin-4-amines 3M INNOVATIVE PROPERTIES COMPANY 2003-12-18 US disclosed
WO-2003101949-A2 PROCESS FOR IMIDAZO[4,5-C]PYRIDIN-4-AMINES 3M INNOVATIVE PROPERTIES COMPANY (US) 2003-12-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030232852-A1 Process for imidazo[4,5-c]pyridin-4-amines CPNE4, HTR4, IL4 LMNA 2300/4885TP53 3168/4885PDCD1 693/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.